Ribi ImmunoChem Research Inc said Baxter Travenol Laboratories Inc's Travenol Laboratories Inc unit will evaluate whether one of its products can be used to prevent infectious disease. Under an agreement, Ribi said Travenol will conduct studies with the product, monophosphoryl lipid A, and will have the option to pursue a woldwide license for the product. Ribi said the product is used in combination with other agents in experimental treatments to boost the function of the immune system in patients suffering from malignant melanoma and other cancers. 